Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Bone injection gun is an intraosseous infusion device used in immediate medical intervention. It can be used in pediatric patients as well as in adults; for person over 12 years the preferred site of administration is proximal tibia 2 cm medial and 1 cm proximal to tibial tuberosity and for less than 12 year age it is 1 cm medial and 2 cm distal to tibial tuberosity.
The global intraosseous infusion devices market is estimated to account for US$ 5,864.7 Mn in terms of value by the end of 2027.
Global Intraosseous Infusion Devices Market: Drivers
Increasing number of emergency surgeries is expected to propel growth of the global intraosseous infusion devices market over the forecast period. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.
Moreover, increasing number of road accidents is also expected to aid in growth of the global intraosseous infusion devices market. For instance, according to the Ministry of Road Transport and Highways, Government of India, in 2018, the number of road accidents increased by 0.46% compared to 2017.
North America held dominant position in the global intraosseous infusion devices market in 2019, accounting for 38.8% share in terms of Value, followed by Europe and Asia Pacific, respectively.
Figure 1: Global Intraosseous Infusion Devices Market Share (%) Value, By Region, 2019
Global Intraosseous Infusion Devices Market: Restraints
Possibility of compartment syndrome due to gushing of fluids and drugs into soft tissues is expected to hinder growth of the global intraosseous infusion devices market. Extravasation is a complication, which can be common effect of IO infusion. The improper manual insertion of the needle may cause gushing of fluids and blood and their deposit into body tissue. Due to the recessive factor such as compartment syndrome and extravasation, the intraosseous infusion system is expected to be affected.
Moreover, limitations for individuals with severe osteoporosis and hypovolemic conditions is also expected to limit growth of the global intraosseous infusion devices market. Intraosseous infusion is a valuable process in terms of rapid fluid administration but limitations such as hypovolemia and severe osteoporosis can prove to be an obstacle for the market.
Intraosseous Infusion Devices Market Report Coverage
||Market Size in 2020:
||US$ 3,575.7 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 5,864.7 Mn
- North America: U.S., Canada
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
- Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: North Africa, Central Africa, South Africa
- By Product Type: B.I.G, FAST1, EZ-IO, FAST Responder, Intraosseous Needles, Others.
- By Technology: Automatic, Manual.
- By Route of Administration: Sternum, Distal and Proximal Tibia, Distal Femur, Calcaneus, Head of Humorous.
- By End User: EMS, Hospital, Ambulatory and Surgical Centers, Cardiology Clinics.
PerSys Medical, Aero Healthcare, Vidacare, Teleflex Incorporated, Implox Pty Ltd., PAVmed, Biopsybell, SAM Medical, Piper Access, LLC, Becton Dickinson Company / Carefusion Inc., and Cook Medical Inc.
- Increasing surgical procedures
- Approval and launch of new products
|Restraints & Challenges:
Global Intraosseous Infusion Devices Market: Opportunities
Greater focus on designing automated intraosseous infusion devices is expected to offer lucrative growth opportunities for players in the global intraosseous infusion devices market. Automated infusion is considered to be safe for use for patients aged 6 years and below. Intraosseous access can be carried out by semi-skilled healthcare givers with minimal training as compared to IV access that required administration by skilled professionals. Automated intraosseous access could prove largely useful in emergency settings in military and rescue scenarios, where rapid access may be crucial and peripheral venous access may be hard to obtain.
Moreover, increasing demand for in intraosseous infusion in vascular resuscitation is also expected to aid in growth of the market.
The global intraosseous infusion devices market was valued at US$ 3,575.7 Mn in 2020 and is forecast to reach a value of US$ 5,864.7 Mn by 2027 at a CAGR of 7.3% between 2020 and 2027.
Figure 2: Global Intraosseous Infusion Devices Market Value (US$ Mn), 2016 – 2027
Market Trends/Key Takeaways
Major players in the global intraosseous infusion devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2020, SAM Medical launched SAM IO Intraosseous Access System for pre-hospital and hospital healthcare providers in the civilian and military sectors.
Moreover, launch of emergency medical training simulators is also expected to aid in growth of the global intraosseous infusion devices market. For instance, in May 2018, TraumaFX, a division of Kforce Government Solutions, Inc. and a global provider of ruggedized human and canine medical training simulators, launched K9 Diesel, a canine medical simulator.
Global Intraosseous Infusion Devices Market: Competitive Landscape
Major players operating in the global intraosseous infusion devices market include, PerSys Medical, Aero Healthcare, Vidacare, Teleflex Incorporated, Implox Pty Ltd., PAVmed, Biopsybell, SAM Medical, Piper Access, LLC, Becton Dickinson Company / Carefusion Inc., and Cook Medical Inc.
Global Intraosseous Infusion Devices Market: Key Developments
Major players in the global intraosseous infusion devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in November 2019, Piper Access, LLC received FDA 510(k) clearance for Piper Go-IO Intraosseous Infusion System from Piper Access.